MeSH term | MeSH ID | Detail |
---|---|---|
Hypothermia | D007035 | 19 associated lipids |
Hypertension | D006973 | 115 associated lipids |
Edema | D004487 | 152 associated lipids |
Catalepsy | D002375 | 30 associated lipids |
Amnesia | D000647 | 12 associated lipids |
Elaidamide is a lipid of Fatty Acyls (FA) class. Elaidamide is associated with abnormalities such as Wiskott-Aldrich Syndrome. The involved functions are known as inhibitors, salivary gland development and branching morphogenesis.
To understand associated biological information of Elaidamide, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Elaidamide is suspected in and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Elaidamide
MeSH term | MeSH ID | Detail |
---|---|---|
Hypothermia | D007035 | 19 associated lipids |
Hypertension | D006973 | 115 associated lipids |
Edema | D004487 | 152 associated lipids |
Catalepsy | D002375 | 30 associated lipids |
Amnesia | D000647 | 12 associated lipids |
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
Function | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Mendelson WB and Basile AS | The hypnotic actions of the fatty acid amide, oleamide. | 2001 | Neuropsychopharmacology | pmid:11682271 |
Basile AS et al. | Characterization of the hypnotic properties of oleamide. | 1999 | Neuroreport | pmid:10321465 |
Laposky AD et al. | Deletion of the GABA(A) receptor beta 3 subunit eliminates the hypnotic actions of oleamide in mice. | 2001 | Neuroreport | pmid:11742254 |
Mendelson WB and Basile AS | The hypnotic actions of oleamide are blocked by a cannabinoid receptor antagonist. | 1999 | Neuroreport | pmid:10574567 |
Murillo-RodrÃguez E et al. | Oleamide modulates memory in rats. | 2001 | Neurosci. Lett. | pmid:11684340 |
Yang JY et al. | Oleamide attenuates apoptotic death in cultured rat cerebellar granule neurons. | 2002 | Neurosci. Lett. | pmid:12133580 |
Egertová M et al. | Fatty acid amide hydrolase expression in rat choroid plexus: possible role in regulation of the sleep-inducing action of oleamide. | 2000 | Neurosci. Lett. | pmid:10713385 |
MartÃnez-González D et al. | Oleamide and anandamide effects on food intake and sexual behavior of rats. | 2004 | Neurosci. Lett. | pmid:15193744 |
Oh YT et al. | Oleamide suppresses lipopolysaccharide-induced expression of iNOS and COX-2 through inhibition of NF-kappaB activation in BV2 murine microglial cells. | 2010 | Neurosci. Lett. | pmid:20298753 |
Kruk-Slomka M et al. | The Influence of the CB1 Receptor Ligands on the Schizophrenia-Like Effects in Mice Induced by MK-801. | 2016 | Neurotox Res | pmid:27577742 |